½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1576845

¼¼°èÀÇ ±Û·çŸ¹Î ½ÃÀå : À¯Çü, ÇüÅÂ, µî±Þ, °ø±Þ¿ø, À¯Åë ä³Î, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Glutamine Market by Type (D-glutamine, L-glutamine), Form (Capsules, Liquids, Powder), Grade, Source, Distribution Channel, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±Û·çŸ¹Î ½ÃÀåÀº 2023³â¿¡ 1¾ï 3,120¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 1¾ï 3,548¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.52%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 1¾ï 7,881¸¸ ´Þ·¯·Î µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áß¿äÇÑ ¾Æ¹Ì³ë»êÀÎ ±Û·çŸ¹ÎÀÇ ¼¼°è´Â ´Ü¹éÁú ÇÕ¼º°ú ¸é¿ª ±â´ÉÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ »ý¸®Àû °úÁ¤¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, Àå³» ȯ°æÀÇ °³¼±°ú ±ÙÀ°ÀÇ È¸º¹°ú °°Àº ÀáÀçÀûÀÎ °Ç°­ È¿°ú¸¦ °¡Á®¿É´Ï´Ù. ±Û·çŸ¹ÎÀÇ ¼¼°èÀÇ Çʿ伺Àº Àå°ú ¸é¿ª°è¿Í °°Àº ±Þ¼ÓÇÏ°Ô ºÐ¿­ÇÏ´Â ¼¼Æ÷ÀÇ ¿¬·á·Î ÀÛ¿ëÇÏ´Â ½ºÆ®·¹½º¿Í »óÇØÀÇ È¸º¹¿¡ Áß¿äÇÑ °ü¿©¿¡ ÀÇÇØ °­Á¶µË´Ï´Ù. ±Û·çŸ¹ÎÀÇ ¼¼°è ¿ëµµ´Â ÀǾàÇ°, ¿µ¾ç º¸ÃæÁ¦, ÆÛ½º³ÎÄɾî, ½ÄÀ½·á ¹× ¼±¼ö, Áߺ´ ȯÀÚ, °Ç°­ ¾ÖÈ£°¡ µî ÃÖÁ¾ »ç¿ëÀÚ¿¡°Ô ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. °Ç°­ ÁöÇâ Áõ°¡, ³ëÈ­, »ýÈ° ½À°üº´ Áõ°¡·Î ½ÃÀå ±Ô¸ð´Â ¼¼°èÀûÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ÇÇÆ®´Ï½º »ê¾÷ÀÇ È®´ë, Ä¡·á °¡´É¼º¿¡ ´ëÇÑ ¿¬±¸ ÁøÇà, Çõ½ÅÀûÀÎ º¸ÃæÁ¦ ¹× ½Å¾à¿¡ ´ëÇÑ ÀÀ¿ëÀ» ¹èÇÕ ÇÒ ¼öÀÖ´Â ±âȸ°¡ Æ÷ÇԵ˴ϴÙ. ±×·¯³ª ±ÔÁ¦»óÀÇ Àå¾Ö¹°°ú ½ÃÀå Æ÷È­ µîÀÇ °úÁ¦µµ ³²¾Æ ÀÖÀ¸¸ç, ÀϺο¡¼­´Â À¯È¿¼º¿¡ ´ëÇÑ È¸ÀÇÀûÀÎ °ßÇصµ ÀÖ½À´Ï´Ù. Çõ½ÅÀ» À§ÇÑ ÃÖ¼±ÀÇ ¿µ¿ªÀº »ýüÀÌ¿ë·üÀ» Çâ»ó½ÃŲ Á¦Çü°ú ´ë»ç ÀÌ»ó Ä¡·á¿¡¼­ ±Û·çŸ¹ÎÀÇ ¼¼°èÀû ¿ªÇÒÀ» Ž±¸ÇÏ´Â °ÍÀÔ´Ï´Ù. ½ÃÀå Á¶»ç¿¡ ÀÇÇϸé õ¿¬ ¼ººÐÀ» Ãß±¸ÇÏ´Â °æÇâÀÌ °­ÇØÁö°í ÀÖÀ¸¸ç, ±Û·çŸ¹ÎÀÇ ¼¼°è ±â¹Ý Á¦Ç°À» À¯±â³ó ¶Ç´Â ½Ä¹° À¯·¡·Î ÇÔÀ¸·Î½á À±¸®Àû ÀǽÄÀÌ ³ôÀº ¼ÒºñÀÚ¿¡°Ô ¾îÇÊÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ À£´Ï½º ÇÁ·Î±×·¥À̳ª ½ºÆ÷Ã÷ ´Üü¿ÍÀÇ Á¦ÈÞ °¡´É¼ºµµ ½ÃÀå¿¡ÀÇ Ä§Åõ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ±× °¡´É¼º°ú´Â ¹Ý´ë·Î º¸ÃæÁ¦ÀÇ Ç¥½Ã¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦¿Í À¯»çÇÑ È¿°ú¸¦ ÀÚ¶ûÇÏ´Â ´ëü ¼ººÐ°úÀÇ ÀáÀçÀû °æÀïÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ ¹æÇعÞÀ» ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ±â¾÷Àº ¸íÈ®ÇÏ°í Á¶»ç¸¦ µÞ¹ÞħÇÏ´Â °Ç°­»óÀÇ ÀÌÁ¡À» ÀÔÁõÇϸ鼭 ÄÄÇöóÀ̾𽺸¦ º¸ÀåÇؾßÇÕ´Ï´Ù. ¼º°øÇϱâ À§Çؼ­´Â ±â¾÷Àº ÀÓ»ó ¿¬±¸¿¡ ÅõÀÚÇÏ¿© Á¦Ç°ÀÇ È¿´ÉÀ» °­È­ÇÏ°í Á¡Á¡ ´õ ºýºýÇÑ ½ÃÀå¿¡¼­ °æÀï·ÂÀ» ³ô¿©¾ßÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 1¾ï 3,120¸¸ ´Þ·¯
¿¹Ãø³â(2024) 1¾ï 3,548¸¸ ´Þ·¯
¿¹Ãø³â(2030) 1¾ï 7,881¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 4.52%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ±Û·çŸ¹Î ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

±Û·çŸ¹Î ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆľÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ºÆ÷Ã÷ ¿µ¾ç ¹× ÇÇÆ®´Ï½º ¾÷°è¿¡¼­ ±Û·çŸ¹ÎÀÇ ¼¼°è º¸Ãæ ¼ö¿ä Áõ°¡
    • ¸¸¼º Áúȯ Áõ°¡¿¡ ÀÇÇÑ ÀÇ·á¿ë ±Û·çŸ¹ÎÀÇ ¼¼°èÀÇ ¿ä±¸ Áõ°¡
    • ÀüÀÚ»ó°Å·¡ÀÇ È®´ë¿¡ ÀÇÇÑ ±Û·çŸ¹ÎÀÇ ¼¼°è Á¦Ç°ÀÇ º¸±Þ°ú À¯ÅëÀÇ ÃËÁø
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±Û·çŸ¹ÎÀÇ ¼¼°è °¡°Ý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Á¦Á¶ ¹× Á¤Á¦ °øÁ¤°ú °ü·ÃµÈ °úµµÇÑ ºñ¿ë
  • ½ÃÀå ±âȸ
    • ½Ä¹°¼º ´Ü¹éÁú ÆÄ¿ì´õ³ª Á¦Ç°¿¡ À־ÀÇ ±Û·çŸ¹ÎÀÇ ¼¼°è °­È­¿¡ ´ëÇÑ °ü½ÉÀÇ °íÁ¶
    • ±ÙÀ°ÀÇ ¼èÅð¿Í ½Î¿ì±â À§ÇÑ °í·ÉÀÚ ¿µ¾ç¿¡ À־ÀÇ ±Û·çŸ¹ÎÀÇ ¼¼°èÀÇ »ç¿ë Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • ±Û·çŸ¹Î ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡´Â ±ÔÁ¦ÀÇ ¾ö°ÝÈ­¿Í ÄÄÇöóÀ̾𽺠¿ä°Ç

Porter's Five Forces: ±Û·çŸ¹Î ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ±Û·çŸ¹Î ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡ÇÏ°í Àü·«Àû ±âȸ¸¦ Ž±¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» È°¿ëÇÏ°í, ¾àÁ¡À» ÇØ°áÇÏ°í, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±Û·çŸ¹Î ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆľÇ

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ±Û·çŸ¹Î ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ±Û·çŸ¹Î ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆľÇ

±Û·çŸ¹Î ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ±Û·çŸ¹Î ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ±Û·çŸ¹Î ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®ÇÏ°í Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆľÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ±Û·çŸ¹Î ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

±Û·çŸ¹Î ½ÃÀå Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆľÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ È°¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆľÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D È°µ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇÏ°í ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ½ºÆ÷Ã÷ ¿µ¾ç, ÇÇÆ®´Ï½º ¾÷°è¿¡ À־ÀÇ ±Û·çŸ¹ÎÀÇ ¼¼°è º¸ÃæÁ¦ ¼ö¿ä Áõ°¡
      • ¸¸¼º Áúȯ Áõ°¡¿¡ ÀÇÇØ ÀÇ·á ±×·¹À̵åÀÇ ±Û·çŸ¹ÎÀÇ ¼¼°èÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ´Ù
      • E-CommerceÀÇ È®´ë¿¡ ÀÇÇØ ±Û·çŸ¹ÎÀÇ ¼¼°è Á¦Ç°ÀÇ º¸´Ù ±¤¹üÀ§ÇÑ ÀÔ¼ö¿Í À¯ÅëÀÌ ÃËÁøµÈ´Ù
    • ¾ïÁ¦¿äÀÎ
      • »ý»ê ¹× Á¤Á¦ °øÁ¤°ú °ü·ÃµÈ °úµµÇÑ ºñ¿ëÀÌ ±Û·çŸ¹ÎÀÇ ¼¼°è °¡°Ý¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù
    • ±âȸ
      • ½Ä¹° À¯·¡ÀÇ ´Ü¹éÁú ºÐ¸» ¹× Á¦Ç°¿¡ À־ÀÇ ±Û·çŸ¹ÎÀÇ ¼¼°è °­È­¿¡ ´ëÇÑ °ü½É Áõ°¡
      • ±ÙÀ°ÀÇ ¼Ò¸ð¸¦ ¾ïÁ¦Çϱâ À§ÇØ °í·ÉÀÚÀÇ ¿µ¾ç¿¡ À־ÀÇ ±Û·çŸ¹ÎÀÇ ¼¼°èÀÇ »ç¿ëÀÌ Áõ°¡
    • °úÁ¦
      • ±Û·çŸ¹Î ½ÃÀå µ¿Çâ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ±ÔÁ¦ ¸ð´ÏÅ͸µ ¹× ±ÔÁ¤ Áؼö ¿ä°Ç ¾ö°ÝÈ­
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ±Û·çŸ¹Î ½ÃÀå : À¯Çüº°

  • D-±Û·çŸ¹Î
  • L-±Û·çŸ¹Î

Á¦7Àå ±Û·çŸ¹Î ½ÃÀå : Çüź°

  • ĸ½¶
  • ¾×ü
  • ºÐ¸»
  • ÅÂºí¸´

Á¦8Àå ±Û·çŸ¹Î ½ÃÀå : µî±Þº°

  • ½ÄÇ° µî±Þ
  • ÀǾàÇ° µî±Þ

Á¦9Àå ±Û·çŸ¹Î ½ÃÀå : ¼Ò½ºº°

  • µ¿¹° À¯·¡
  • ¹ßÈ¿ º£À̽º
  • ½Ä¹° À¯·¡

Á¦10Àå ±Û·çŸ¹Î ½ÃÀå : À¯Åë ä³Îº°

  • ¿ÀÇÁ¶óÀÎ
  • ¿Â¶óÀÎ

Á¦11Àå ±Û·çŸ¹Î ½ÃÀå : ¿ëµµº°

  • µ¿¹°¿µ¾ç
  • ÀÓ»ó¿µ¾çÇÐ
  • ¿µ¾çº¸Á¶½ÄÇ°
  • ½ÄÇ° ¹× À½·á
  • ÀǾàÇ°
  • ½ºÆ÷Ã÷ ¿µ¾ç

Á¦12Àå ¾Æ¸Þ¸®Ä« ±Û·çŸ¹Î ½ÃÀå

  • ¾Æ¸£ÇîƼ³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦13Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±Û·çŸ¹Î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦14Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±Û·çŸ¹Î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍÅ°
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • ANI Pharmaceuticals, FDA ½ÂÀÎÀÇ L-±Û·çŸ¹Î °æ±¸ ºÐ¸»À» ¹ß¸Å
    • Glanbia plc°¡ Flavor Producers LLC¸¦ ÃÖ´ë 3¾ï 5,500¸¸ ´Þ·¯·Î Àμö
    • Fibrolamellar Cancer FoundationÀº Dracen Pharmaceuticals°ú Á¦ÈÞÇØ, FLC Á¾¾ç¿¡ À־ÀÇ ±Û·çŸ¹ÎÀÇ ¼¼°è ÀÇÁ¸¼ºÀ» Ç¥ÀûÀ¸·Î ÇÏ´Â DRP-104¸¦ ¿¬±¸ÇÏ°í ÀÖ½À´Ï´Ù.
  • Àü·« ºÐ¼®°ú Á¦¾È
BJH 24.10.31

The Glutamine Market was valued at USD 131.20 million in 2023, expected to reach USD 135.48 million in 2024, and is projected to grow at a CAGR of 4.52%, to USD 178.81 million by 2030.

Glutamine, a vital amino acid, plays a significant role in various physiological processes, including protein synthesis and immune function, and offers potential health benefits like improved gut health and muscle recovery. The necessity for glutamine is underscored by its critical involvement in stress and injury recovery, where it acts as a fuel for rapidly dividing cells, such as those in the intestines and immune system. Applications of glutamine span across pharmaceuticals, dietary supplements, personal care, and food & beverages, serving end-users like athletes, patients with critical illnesses, and wellness enthusiasts. The market scope extends globally, driven by increasing health consciousness, the aging population, and rising rates of lifestyle diseases. Key factors influencing growth include an expanding fitness industry and ongoing research into its therapeutic potential, while opportunities abound in formulating innovative supplements and novel drug applications. However, challenges persist, such as regulatory hurdles and market saturation, alongside skepticism about efficacy from some quarters. The best areas for innovation involve enhanced bioavailability formulations and exploring glutamine's role in treating metabolic disorders, which could unlock new segments in personalized nutrition and precision medicine. Market research indicates a growing trend toward natural ingredients, suggesting that positioning glutamine-based products as organic or plant-derived could appeal to ethically conscious consumers. Additionally, potential partnerships with wellness programs and sports organizations could enhance market penetration. Despite its potential, market growth could be hampered by strict regulations in supplement labeling and potential competition from alternative ingredients boasting similar benefits. Thus, businesses should ensure compliance while demonstrating clear, research-backed health benefits. To thrive, companies should invest in clinical studies that strengthen the efficacy claims of glutamine products, enhancing their competitive edge in an increasingly discerning market.

KEY MARKET STATISTICS
Base Year [2023] USD 131.20 million
Estimated Year [2024] USD 135.48 million
Forecast Year [2030] USD 178.81 million
CAGR (%) 4.52%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glutamine Market

The Glutamine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for glutamine supplements in sports nutrition and fitness industry
    • Rising prevalence of chronic diseases driving the need for medical-grade glutamine
    • Expansion of e-commerce facilitating wider availability and distribution of glutamine products
  • Market Restraints
    • Excessive costs associated with production and purification processes impacting glutamine prices
  • Market Opportunities
    • Growing interest in glutamine fortification in plant-based protein powders and products
    • Increasing use of glutamine in elderly nutrition to combat muscle wastage
  • Market Challenges
    • Stricter regulatory scrutiny and compliance requirements affecting glutamine market dynamics

Porter's Five Forces: A Strategic Tool for Navigating the Glutamine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glutamine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glutamine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glutamine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glutamine Market

A detailed market share analysis in the Glutamine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glutamine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glutamine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glutamine Market

A strategic analysis of the Glutamine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glutamine Market, highlighting leading vendors and their innovative profiles. These include Advanced Glutamine, Ajinomoto Co., Inc., Alfa Chemistry, Cargill, Incorporated, Daesang Corporation, Evonik Industries AG, Glanbia plc, Jarrow Formulas, Inc., Kyoto Kagaku Co., Ltd., KYOWA HAKKO BIO CO., LTD., Life Extension Foundation, Merck KGaA, NOW Foods, NutraBio Labs, Inc., Nutricost, Prince Pharma, Scitec Nutrition, Shijiazhuang Jirong Pharmaceutical Co., Ltd., Sichuan Tongsheng Amino Acid Co., Ltd., and Tocris Bioscience.

Market Segmentation & Coverage

This research report categorizes the Glutamine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across D-glutamine and L-glutamine.
  • Based on Form, market is studied across Capsules, Liquids, Powder, and Tablets.
  • Based on Grade, market is studied across Food Grade and Pharmaceutical Grade.
  • Based on Source, market is studied across Animal-based, Fermentation-based, and Plant-based.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Application, market is studied across Animal Nutrition, Clinical Nutrition, Dietary Supplements, Food & Beverages, Pharmaceuticals, and Sports Nutrition.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for glutamine supplements in sports nutrition and fitness industry
      • 5.1.1.2. Rising prevalence of chronic diseases driving the need for medical-grade glutamine
      • 5.1.1.3. Expansion of e-commerce facilitating wider availability and distribution of glutamine products
    • 5.1.2. Restraints
      • 5.1.2.1. Excessive costs associated with production and purification processes impacting glutamine prices
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing interest in glutamine fortification in plant-based protein powders and products
      • 5.1.3.2. Increasing use of glutamine in elderly nutrition to combat muscle wastage
    • 5.1.4. Challenges
      • 5.1.4.1. Stricter regulatory scrutiny and compliance requirements affecting glutamine market dynamics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glutamine Market, by Type

  • 6.1. Introduction
  • 6.2. D-glutamine
  • 6.3. L-glutamine

7. Glutamine Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Liquids
  • 7.4. Powder
  • 7.5. Tablets

8. Glutamine Market, by Grade

  • 8.1. Introduction
  • 8.2. Food Grade
  • 8.3. Pharmaceutical Grade

9. Glutamine Market, by Source

  • 9.1. Introduction
  • 9.2. Animal-based
  • 9.3. Fermentation-based
  • 9.4. Plant-based

10. Glutamine Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Glutamine Market, by Application

  • 11.1. Introduction
  • 11.2. Animal Nutrition
  • 11.3. Clinical Nutrition
  • 11.4. Dietary Supplements
  • 11.5. Food & Beverages
  • 11.6. Pharmaceuticals
  • 11.7. Sports Nutrition

12. Americas Glutamine Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Glutamine Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Glutamine Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. ANI Pharmaceuticals launches FDA-approved L-Glutamine Oral Powder
    • 15.3.2. Glanbia plc acquires Flavor Producers LLC for up to USD 355 million
    • 15.3.3. Fibrolamellar Cancer Foundation partners with Dracen Pharmaceuticals to study DRP-104 targeting glutamine dependence in FLC tumors
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Glutamine
  • 2. Ajinomoto Co., Inc.
  • 3. Alfa Chemistry
  • 4. Cargill, Incorporated
  • 5. Daesang Corporation
  • 6. Evonik Industries AG
  • 7. Glanbia plc
  • 8. Jarrow Formulas, Inc.
  • 9. Kyoto Kagaku Co., Ltd.
  • 10. KYOWA HAKKO BIO CO., LTD.
  • 11. Life Extension Foundation
  • 12. Merck KGaA
  • 13. NOW Foods
  • 14. NutraBio Labs, Inc.
  • 15. Nutricost
  • 16. Prince Pharma
  • 17. Scitec Nutrition
  • 18. Shijiazhuang Jirong Pharmaceutical Co., Ltd.
  • 19. Sichuan Tongsheng Amino Acid Co., Ltd.
  • 20. Tocris Bioscience
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦